rdna semaglutide real‑world outcomes
Stop Using Semaglutide 2.4 mg. Do This Instead
Semaglutide 2.4 mg does appear to lower heart-attack and stroke risk more than the 1.0 mg dose, based on both randomized trials and large observational studies. Clinicians are now weighing whether the extra milligrams justify the higher cost and potential side effects, especially as obesity treatment becomes a